McMurray J, Francis M
Department of Cardiology, Western General Hospital, Edinburgh.
Br J Clin Pract. 1994 Jan-Feb;48(1):29-36.
Chronic heart failure (CHF) is common, disabling and deadly. Recent studies show that ACE inhibitors reduce morbidity and mortality in all grades of CHF and may even delay or prevent the onset of overt CHF in patients with asymptomatic left ventricular dysfunction. In this review, guidelines are given for how to use these drugs both in hospital and in general practice. New evidence on the benefits of digoxin is also considered, and the management of concomitant problems such as angina and arrhythmias in patients with CHF is discussed.
慢性心力衰竭（CHF）常见、致残且致命。近期研究表明，血管紧张素转换酶（ACE）抑制剂可降低各级慢性心力衰竭的发病率和死亡率，甚至可能延缓或预防无症状左心室功能不全患者出现明显的心力衰竭。在这篇综述中，给出了关于在医院和一般临床实践中如何使用这些药物的指南。还考虑了关于地高辛益处的新证据，并讨论了慢性心力衰竭患者合并症如心绞痛和心律失常的管理。
